HYBRID EVENT: Join us in person in Singapore or attend virtually from anywhere.

3rd Edition of International Cancer & Immuno-Oncology Conference

March 15-17, 2027 | Singapore
March 15-17, 2027 | Singapore

Iris Melanocytic Tumor

Iris Melanocytic Tumor

Iris melanocytic tumors are rare intraocular growths originating from melanocytes, the cells responsible for producing pigment. While often benign, some can progress to melanoma, a potentially deadly form of cancer. Research in this field aims to better understand the genetic and environmental factors influencing tumor development, as well as to improve diagnostic techniques for early detection. Advanced imaging technologies and genetic testing have enabled more accurate assessment of tumor characteristics, aiding in treatment decisions and prognostic evaluation. Additionally, targeted therapies are being explored to specifically inhibit pathways involved in tumor growth and spread. Continued investigation into iris melanocytic tumors holds promise for improved patient outcomes through personalized treatment approaches and enhanced surveillance strategies.

Committee Members
Committee Member - Michael Thompson

Michael Thompson

University of Toronto, Canada
Committee Member - Pietro Salvatori

Pietro Salvatori

Formerly, Humanitas San Pio X Hospital, Italy
Committee Member - Rajvir Dahiya

Rajvir Dahiya

University of California San Francisco, United States

Submit your abstract Today

YouTube
WhatsAppWhatsApp